Search - Université de Rennes Access content directly

Filter your results

11 Results
authFullName_s : Filomena Conti

No evidence of hepatitis B virus reactivation among liver transplant recipients treated with interferon- free regimens for hepatitis C virus recurrence (ANRS CO23 CUPILT Cohort)

Lina Mouna , Emilie Rossignol , Mariagrazia Tateo , Jean-Charles Duclos-Vallee , Christophe Duvoux et al.
Hepatology, 2017, 66, pp.873A-874A
Journal articles hal-01769634v1
Image document

Efficacy and Safety of Everolimus and Mycophenolic Acid With Early Tacrolimus Withdrawal After Liver Transplantation: A Multicenter Randomized Trial

Faouzi Saliba , Christophe Duvoux , Jean Gugenheim , Nassim Kamar , Sébastien Dharancy et al.
American Journal of Transplantation, 2017, 17 (7), pp.1843-1852. ⟨10.1111/ajt.14212⟩
Journal articles hal-01558819v1

Hepatitis B virus reactivation in transplant patients treated for hepatitis C recurrence Prophylaxis makes the difference

Lina Mouna , Emilie Rossignol , Mariagrazia Tateo , Audrey Coilly , Jean-Charles Duclos-Vallee et al.
Journal of Hepatology, 2019, 70 (6), pp.1297-1300. ⟨10.1016/j.jhep.2019.02.019⟩
Journal articles hal-02120675v1

Multicentre experience using daclatasvir and sofosbuvir to treat hepatitis C recurrence - The ANRS CUPILT study

Audrey Coilly , Claire Fougerou-Leurent , Victor De Ledinghen , Pauline Houssel-Debry , Christophe Duvoux et al.
Journal of Hepatology, 2016, 65 (4), pp.711--718. ⟨10.1016/j.jhep.2016.05.039⟩
Journal articles hal-01395132v1

Inevitability of disease recurrence after liver transplantation for NAFLD cirrhosis

François Villeret , Sébastien Dharancy , Domitille Erard , Armand Abergel , Louise Barbier et al.
JHEP Reports Innovation in Hepatology, 2023, 5 (3), pp.100668. ⟨10.1016/j.jhepr.2022.100668⟩
Journal articles hal-04020048v1

Comparison of the effect of direct-acting antiviral with and without ribavirin on cyclosporine and tacrolimus clearance values results from the ANRS CO23 CUPILT cohort

Aurélie Barrail-Tran , Lauriane Goldwirt , Thibaut Gelé , Claire Laforest , Audrey Lavenu et al.
European Journal of Clinical Pharmacology, 2019, 75 (11), pp.1555-1563. ⟨10.1007/s00228-019-02725-x⟩
Journal articles hal-02280498v1
Image document

Microsporidiosis after liver transplantation: A French nationwide retrospective study

Jérôme Dumortier , Sylvie Radenne , Nassim Kamar , Filomena Conti , Armand Abergel et al.
Transplant Infectious Disease, 2021, pp.e13665. ⟨10.1111/tid.13665⟩
Journal articles hal-03280899v1
Image document

International study on the outcome of locoregional therapy for liver transplant in hepatocellular carcinoma beyond Milan criteria

Helena Degroote , Federico Piñero , Charlotte Costentin , Andrea Notarpaolo , Ilka F Boin et al.
JHEP Reports Innovation in Hepatology, 2021, 3 (5), pp.100331. ⟨10.1016/j.jhepr.2021.100331⟩
Journal articles hal-03378783v2

Patients Treated for HCV Infection and Listed for Liver Transplantation in a French Multicenter Study: What Happens at Five Years?

Lucy Meunier , Mohamed Belkacemi , George Philippe Pageaux , Sylvie Radenne , Anaïs Vallet-Pichard et al.
Viruses, 2023, 15 (1), pp.137. ⟨10.3390/v15010137⟩
Journal articles hal-03980202v1

Sofosbuvir and NS5A inhibitors without Ribavirin during 12 weeks are efficient to treat hepatitis C recurrence after liver transplantation only in genotype 1. Results from the CO23 ANRS CUPILT study.

Pauline Houssel-Debry , Audrey Coilly , Claire Fougerou-Leurent , Caroline Jezequel , Christophe Duvoux et al.
Hepatology, 2017, 63 (1 SUPP), pp.465A--465A
Journal articles hal-01412958v1

12 weeks of a Ribavirin-free Sofosbuvir and NS5A inhibitor regimen is enough to treat recurrence of hepatitis C after liver transplantation

Pauline Houssel-Debry , Audrey Coilly , Claire Fougerou-Leurent , Caroline Jezequel , Christophe Duvoux et al.
Hepatology, 2018, 68 (4), pp.1277-1287. ⟨10.1002/hep.29918⟩
Journal articles hal-01807755v1